Hyaluronidase Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hyaluronidase stocks.

Hyaluronidase Stocks Recent News

Date Stock Title
May 10 AMPH Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
May 10 HALO Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled Breakout
May 10 AMPH Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
May 9 AMPH Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
May 9 AMPH Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
May 9 AMPH Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
May 9 AMPH Amphastar Pharmaceuticals Inc (AMPH) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
May 9 AMPH Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2024 Earnings Call Transcript
May 8 AMPH Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings and Revenue Estimates
May 8 AMPH Amphastar Pharmaceuticals Non-GAAP EPS of $1.04 beats by $0.25, revenue of $171.8M misses by $2.91M
May 8 AMPH Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
May 8 HALO Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2024 Earnings Call Transcript
May 8 HALO Halozyme's (HALO) Q1 Earnings Beat, Revenues Lag Estimates
May 8 HALO Q1 2024 Halozyme Therapeutics Inc Earnings Call
May 8 HALO Halozyme Therapeutics Inc (HALO) (Q1 2024) Earnings Call Transcript Highlights: Robust Growth ...
May 7 HALO Halozyme Therapeutics, Inc. (HALO) Q1 2024 Earnings Call Transcript
May 7 HALO Halozyme Therapeutics (HALO) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
May 7 HALO Halozyme Therapeutics Q1 2024 Earnings: Misses EPS Estimates but Shows Revenue Growth
May 7 HALO Halozyme Therapeutics (HALO) Q1 Earnings Beat Estimates
May 7 AMPH Amphastar Pharmaceuticals Q1 2024 Earnings Preview
Hyaluronidase

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). Karl Meyer classified these enzymes in 1971 into three distinct groups, a scheme based on the enzyme reaction products. The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.In humans, there are five functional hyaluronidases: HYAL1, HYAL2, HYAL3, HYAL4 and HYAL5 (also known as SPAM1 or PH-20); plus a pseudogene, HYAL6 (also known as HYALP1). The genes for HYAL1-3 are clustered in chromosome 3, while HYAL4-6 are clustered in chromosome 7. HYAL1 and HYAL2 are the major hyaluronidases in most tissues. GPI-anchored HYAL2 is responsible for cleaving high-molecular weight HA, which is mostly bound to the CD44 receptor. The resulting HA fragments of variable size are then further hydrolized by HYAL1 after being internalized into endo-lysosomes; this generates HA oligosaccharides.According to their enzymatic mechanism, hyaluronidases are hyaluronoglucosidases (EC 3.2.1.35), i.e. they cleave the (1->4)-linkages between N-acetylglucosamine and glucuronate. The term hyaluronidase may also refer to hyaluronoglucuronidases (EC 3.2.1.36), which cleave (1->3)-linkages. In addition, bacterial hyaluronate lyases (EC 4.2.2.1) may also be referred to as hyaluronidases, although this is uncommon.

Browse All Tags